Exicure (XCUR) Interest Expenses (2016 - 2025)

Exicure (XCUR) reported Interest Expenses of $1000.0 for Q4 2025, down 91.67% quarter-over-quarter from $12000.0 in Q3 2024.

Exicure (XCUR) Interest Expenses (2016 - 2025) Analysis & Trends

Exicure has reported Interest Expenses for 9 years, with the latest figure at $1000.0 in Q4 2025.

For the quarter ending Q4 2025, Interest Expenses changed N/A year-over-year to $1000.0; the trailing twelve-month figure through Mar 2026 stood at $1000.0 (down 94.44% YoY), and the FY2025 full-year result was $1000.0, down 94.44% from the prior year.
Interest Expenses for Q4 2025 stood at $1000.0, down from $12000.0 in the prior quarter.
The five-year high for Interest Expenses was $595000.0 in Q1 2022, with the low at $1000.0 in Q4 2025.
Historically, Interest Expenses has averaged $288125.0 across 4 years, with a median of $393000.0 in 2021.
The largest YoY upside for Interest Expenses was 1585.19% in 2021 against a maximum downside of 9.81% in 2021.
Exicure's Interest Expenses stood at $377000.0 in 2021, then soared by 57.82% to $595000.0 in 2022, then sank by 97.98% to $12000.0 in 2024, then sank by 91.67% to $1000.0 in 2025.
The last three Interest Expenses figures came in at $1000.0 (Q4 2025), $12000.0 (Q3 2024), and $6000.0 (Q2 2024), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Int Expense (Qtr)
1	Alterity Therapeutics	719,706.53 Bn	719,706.50 Bn	-	-
2	Belite Bio	55,800.00 Bn	55,800.00 Bn	-	-
3	Quantum Biopharma	18,182.30 Bn	18,182.29 Bn	-	-
4	Legend Biotech	3,154.00 Bn	3,153.71 Bn	242.10 Mn	-5.50 Mn
5	Akari Therapeutics	1,844.30 Bn	1,844.29 Bn	-	61,000.00
6	Evaxion A	1,567.96 Bn	1,567.94 Bn	-	-332,000.00
7	Psyence Biomedical	251.43 Bn	251.42 Bn	-	-2,753.00
8	Vertex Pharmaceuticals	112.56 Bn	105.31 Bn	2.59 Bn	-
9	Abivax	94.37 Bn	94.37 Bn	-	-5.58 Mn
10	Exicure	19.38 Mn	16.77 Mn	-	-

Download Data